Cargando…
Personalizing Diabetes Management in Liver Transplant Recipients: The New Era for Optimizing Risk Management
Post‐transplant diabetes mellitus (PTDM) is a significant contributor to morbidity and mortality in liver transplant recipients (LTRs). With concurrent comorbidities and use of various immunosuppression medications, identifying a safe and personalized regimen for management of PTDM is needed. There...
Autores principales: | Richardson, Brooks, Khan, Mohammad Qasim, Brown, Sara A, Watt, Kymberly D, Izzy, Manhal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134800/ https://www.ncbi.nlm.nih.gov/pubmed/34921530 http://dx.doi.org/10.1002/hep4.1876 |
Ejemplares similares
-
Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation
por: Arab, Juan Pablo, et al.
Publicado: (2021) -
Pancreatic adenocarcinoma in liver transplant recipients: a case series
por: Rauf, Muhammad A., et al.
Publicado: (2021) -
Bariatric surgery proves long-term benefit in patients with cirrhosis
por: Izzy, Manhal, et al.
Publicado: (2020) -
Peripheral Endothelial Function as a Marker of Systemic Vasodilation in End-stage Liver Disease: Results of a Pilot Study
por: Nasser-Ghodsi, Navine, et al.
Publicado: (2020) -
Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?
por: Izzy, Manhal, et al.
Publicado: (2021)